Data gathered: July 15
Alternative Data for Biohaven
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 17,000 | Sign up | Sign up | Sign up |
| Employee Rating | 90 | Sign up | Sign up | Sign up |
| Google Trends | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 13 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,250 | Sign up | Sign up | Sign up |
| Instagram Followers | 2,770 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 37 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,711 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,154 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 988 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 77 | Sign up | Sign up | Sign up |
| Linkedin Employees | 434 | Sign up | Sign up | Sign up |
About Biohaven
Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide.
| Price | $14.19 |
| Target Price | Sign up |
| Volume | 1,340,000 |
| Market Cap | $1.42B |
| Year Range | $13.79 - $53.74 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNJune 23 - GlobeNewswire |
|
 |
Biohaven Ltd. (NYSE:BHVN) Position Boosted by GAMMA Investing LLCJune 23 - ETF Daily News |
|
Analysts Set Biohaven Ltd. (NYSE:BHVN) Price Target at $58.46June 22 - ETF Daily News |
|
Exchange Traded Concepts LLC Sells 719 Shares of Biohaven Ltd. (NYSE:BHVN)June 22 - ETF Daily News |
|
JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $55.00June 19 - ETF Daily News |
|
Biohaven (NYSE:BHVN) Reaches New 1-Year Low Following Analyst DowngradeJune 19 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 0 | 0 | 0 | -222M | -222M | -1.640 |
| Q4 '24 | 0 | 0 | 0 | -187M | -187M | -1.710 |
| Q3 '24 | 0 | 1M | 0 | -160M | -176M | -1.740 |
| Q2 '24 | 0 | 980,000 | -980,000 | -320M | -332M | -3.500 |
| Q1 '24 | 0 | 940,000 | -940,000 | -180M | -182M | -2.200 |
Insider Transactions View All
| CHILDS JOHN W filed to buy 25,291 shares at $30.7. March 5 '25 |
| CHILDS JOHN W filed to buy 76,570 shares at $30.7. March 5 '25 |
| CHILDS JOHN W filed to buy 2,320,571 shares at $30.4. March 5 '25 |
| CHILDS JOHN W filed to buy 2,368,741 shares at $35.9. December 31 '24 |
| Coric Vlad filed to buy 861,942 shares at $47.5. October 3 '24 |
Similar companies
Read more about Biohaven (BHVN) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Biohaven?
The Market Cap of Biohaven is $1.42B.
What is the current stock price of Biohaven?
Currently, the price of one share of Biohaven stock is $14.19.
How can I analyze the BHVN stock price chart for investment decisions?
The BHVN stock price chart above provides a comprehensive visual representation of Biohaven's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Biohaven shares. Our platform offers an up-to-date BHVN stock price chart, along with technical data analysis and alternative data insights.
Does BHVN offer dividends to its shareholders?
As of our latest update, Biohaven (BHVN) does not offer dividends to its shareholders. Investors interested in Biohaven should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Biohaven?
Some of the similar stocks of Biohaven are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.